Limit search to available items
Nearby Subjects are:
Result Page   Prev Next
Add Marked to Bag Add All On Page Add Marked to My Lists
Mark   Year Entries
Immunosuppression -- Risk factors. : The enemy within : the high cost of living near nuclear reactors : breast cancer, AIDS, low birthweights, and other radiation-induced immune deficiency effects / by Jay M. Gould, with members of the Radiation and Public Health Project, Ernest J. Sternglass, Joseph J. Mangano, William McDonnell  1996 1
Immunosuppression -- United States : Low-level radiation and immune system damage : an atomic era legacy / Joseph J. Mangano, the Radiation and Public Health Project, New York, New York  2018 1
 

Immunosuppressions -- See Immunosuppression


Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs
  1
 

Immunosuppressions (Physiology) -- See Immune Tolerance


The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc
  1
  Immunosuppressive Agents -- 5 Related Subjects   5
Immunosuppressive Agents.   10
Immunosuppressive Agents -- adverse effects.   5
Immunosuppressive Agents -- economics. : Extending Medicare coverage for preventive and other services / Marilyn J. Field, Robert L. [i.e. Robert S.] Lawrence, and Lee Zwanziger, editors ; Committee on Medicare Coverage Extensions, Division of Health Care Services, Institute of Medicine  2000 1
Immunosuppressive Agents -- immunology. : Immunosuppressive mechanisms in myeloid cells / Dmitry Gabrilovich  2014 1
Immunosuppressive Agents -- pharmacology.   2
Immunosuppressive agents -- Side effects. : Skin Disease in Organ Transplantation / edited by Clark C. Otley, Thomas Stasko  2008 1
Immunosuppressive agents -- Therapeutic use. : Skin Disease in Organ Transplantation / edited by Clark C. Otley, Thomas Stasko  2008 1
 

Immunosuppressive drugs -- See Immunosuppressive agents


  1
Immunotaxonomy. : Toward precision medicine : building a knowledge network for biomedical research and a new taxonomy of disease / Committee on a framework for developing a new taxonomy of disease ; Board on Life Sciences ; Division on Earth and Life Studies  2011 1
Immunotechnology   2
Immunotechnology -- Periodicals : Immunotechnology (Online)  1999 1
 

Immunotherapies -- See Immunotherapy


Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection
  1
 

Immunotherapies, Active -- See Immunotherapy, Active


Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system
  1
 

Immunotherapies, Adoptive -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
 

Immunotherapies, Adoptive Cellular -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
 

Immunotherapies, Allergen -- See Desensitization, Immunologic


Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
  1
 

Immunotherapies, Passive -- See Immunization, Passive


Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER)
  1
  Immunotherapy -- 3 Related Subjects   3
Immunotherapy.   98
Immunotherapy, Active.   3
Immunotherapy, Active -- methods. : Immunologic adjuvant research / Antonio H. Benvenuto, editor  2009 1
Immunotherapy, Adoptive.   5
 

Immunotherapy, Adoptive Cellular -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
Immunotherapy -- adverse effects. : Handbook of cancer treatment-related toxicities / Vamsidhar Velcheti, Salman R Punekar  2022 1
 

Immunotherapy, Allergen -- See Desensitization, Immunologic


Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
  1
Allergy -- Immunotherapy.   8
Asthma -- Immunotherapy.   2
Autoimmune diseases -- Immunotherapy.   3
Brain -- Tumors -- Immunotherapy. : Translational immunotherapy of brain tumors / edited by John H. Sampson  2017 1
Cancer -- Immunotherapy.   57
Cancer -- Immunotherapy -- Periodicals : Journal for immunotherapy of cancer  2013- 1
Immunotherapy -- Congresses. : Immunotherapy in 2020 : visions and trends for targeting inflammatory disease / A. Radbruch [and others], editors  2007 1
Diabetes -- Immunotherapy. : Development of immunotherapies for type 1 diabetes : value and limitations of mouse models / Matthias von Herrath  2015 1
Diabetes -- Immunotherapy -- Congresses. : Defining optimal immunotherapies for type 1 diabetes  2008 1
Immunotherapy -- Electronic Journals : International immunopharmacology (Online)  2001- 1
Immunotherapy -- ethics. : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors  2004 1
Gastrointestinal system -- Cancer -- Immunotherapy. : Immunotherapy for gastrointestinal cancer / David Kerr, Rebecca Johnson, editors  2017 1
Gliomas -- Immunotherapy. : Glioma : immunotherapeutic approaches / edited by Ryuya Yamanaka  2012 1
Immunotherapy -- Handbooks, manuals, etc   2
HIV infections -- Immunotherapy. : Soluble factors mediating innate immune responses to HIV infection / edited by Massimo Alfano  2010 1
Immunotherapy -- legislation & jurisprudence. : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors  2004 1
Leukemia -- Immunotherapy. : Novel treatment options in lymphoma and leukemia : part 2 of 2 / Nishitha M. Reddy  2017 1
Lymphomas -- Immunotherapy. : Novel treatment options in lymphoma and leukemia : part 2 of 2 / Nishitha M. Reddy  2017 1
Melanoma -- Immunotherapy.   4
Immunotherapy -- methods.   27
Add Marked to Bag Add All On Page Add Marked to My Lists
Result Page   Prev Next